LIR Life Sciences Corp. (CSE:SKNY)

Canada flag Canada · Delayed Price · Currency is CAD
1.900
-0.450 (-19.15%)
At close: Jan 13, 2026
322.22%
Market Cap52.95M
Revenue (ttm)n/a
Net Income (ttm)-566.64K
Shares Out27.87M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume265,733
Average Volume139,599
Open2.360
Previous Close2.350
Day's Range1.500 - 2.370
52-Week Range0.450 - 2.410
Betan/a
RSI55.99
Earnings DateMar 31, 2026

About LIR Life Sciences

LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada. [Read more]

Industry Pharmaceutical Preparations
Founded 2024
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol SKNY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.